ElizabethSKlingsMD
Pulmonology • Boston, MACritical Care Medicine, Pleural Disease
Assistant Professor, Medicine, Boston University School of Medicine
Dr. Klings is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
725 Albany St
Shapiro 9, Suite B
Boston, MA 02118Phone+1 617-638-7480Fax+1 617-638-7486- Is this information wrong?
Education & Training
Boston University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1995 - 2000- Boston University Medical CenterResidency, Internal Medicine, 1992 - 1995
New York University School of MedicineClass of 1992
Certifications & Licensure
MA State Medical License 1994 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Macitentan in Pulmonary Hypertension of Sickle Cell Disease Start of enrollment: 2015 Jul 01
- Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients Start of enrollment: 2019 Jul 26
- STRIDE Biorepository Start of enrollment: 2017 Mar 13
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsRiociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial.Mark T Gladwin, Victor R Gordeuk, Payal C Desai, Caterina Minniti, Enrico M Novelli, Claudia R Morris, Kenneth I Ataga, Laura De Castro, Susanna A Curtis, Fuad El Rass...> ;The Lancet. Haematology. 2024 Mar 27
- Diabetes Screening Rates and Practices in Patients With Sickle Cell Disease.Samantha M Siskind, Terrell Y Johnson, Elizabeth S Klings, Katherine L Modzelewski> ;Diabetes Care. 2024 Mar 15
- Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension.Barberà, J., Jansa, P., Ristić, A., Keogh, A., Solum, D., Rao, Y., Grover, R., Saib, I., Klings, E., Sood, N.> ;Advances in Therapy. 2024 Mar 1
- Join now to see all
Abstracts/Posters
- Patients with Sickle Cell Disease and Venous Thromboembolism Experience Increased Frequency of Vasoocclusive EventsElizabeth S Klings, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Severity Classification for Sickle Cell Disease: A RAND/UCLA Modified Delphi PanelElizabeth S Klings, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- The Effect of Anticoagulant Choice on Venous Thromboembolism Recurrence and Bleeding in Sickle Cell DiseaseElizabeth S Klings, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Other
- Cor pulmonaleKlings ES
http://www.uptodate.com/contents/cor-pulmonale
UpToDate, Wolters Kluwer Health - 2012-07-09
Press Mentions
May 2022 Faculty Appointments, Promotions AnnouncedAugust 17th, 2022
I'm Aware That I'm Rare: Liz Klings, MD (PE and Sickle Cell)August 15th, 2017- I'm Aware That I'm Rare: Liz Klings, MDJune 20th, 2017
Grant Support
- Protein Biomarkers Of Pulmonary Hypertension In Sickle Cell DiseaseNational Heart, Lung, And Blood Institute2012
- Comparative Proteomics Of Sickle Cell Disease-Related Pulmonary HypertensionNational Center For Research Resources2007–2011
- Gene Polymorphism In Chronic Sickle Cell Lung DiseaseNational Heart, Lung, And Blood Institute2005–2009
- Nitrosylation Of Plasma Proteins In Sickle Cell Disease &Pulmonary HypertensionNational Center For Research Resources2005–2006
- Pulmonary Hypertension In Sickle Cell DiseaseNational Center For Research Resources2004–2006
Hospital Affiliations
Boston Medical CenterBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
